OncLive® On Air · Nov 9, 2026 · 17:17
Listen in the Podli app 🎧
Follow your favourite podcasts, listen offline and in the car with CarPlay and Android Auto, and always pick up where you left off. Free to try.
In today’s episode, we welcomed Noa Biran, MD, to discuss some of the key multiple myeloma data to emerge from the 2026 ASCO Annual Meeting. Dr Biran is the medical director of Clinical Protocol Data Management and an associate professor of medicine in the Multiple Myeloma Division at Hackensack Meridian Health and John Theurer Cancer Center in New Jersey.
In the exclusive interview, Dr Biran detailed key data from pivotal studies such as the phase 3 MajesTEC-9 (NCT05572515) and SUCCESSOR-2 (NCT05552976) trials, and explained how emerging data could affect the multiple myeloma treatment landscape.